No Detail Found!

Early Therapeutic Effect for Local Mild Magnetothermy (Hyperthermy) and Dose-Dense PLD in Comprehensive Treatment of Resistant Breast Cancer

Author(s)
Movchan Oleksii Volodimirovich Department of Breast Cancer and Reconstructie Surgery, State Non-commercial Enterprise, National Cancer Institute of the Ministry of Health of Ukraine, Kyiv, Ukraine
Smolanka Ivan Ivanovich Department of Breast Cancer and Reconstructie Surgery, State Non-commercial Enterprise, National Cancer Institute of the Ministry of Health of Ukraine, Kyiv, Ukraine
Lyashenko Andriy Oleksandrovich Department of Breast Cancer and Reconstructie Surgery, State Non-commercial Enterprise, National Cancer Institute of the Ministry of Health of Ukraine, Kyiv, Ukraine
Loboda Anton Dmitrovich Department of Breast Cancer and Reconstructie Surgery, State Non-commercial Enterprise, National Cancer Institute of the Ministry of Health of Ukraine, Kyiv, Ukraine
Ivankova Oksana Mykolaivna Department of Breast Cancer and Reconstructie Surgery, State Non-commercial Enterprise, National Cancer Institute of the Ministry of Health of Ukraine, Kyiv, Ukraine
Dosenko Irina Viktorivna Department of Breast Cancer and Reconstructie Surgery, State Non-commercial Enterprise, National Cancer Institute of the Ministry of Health of Ukraine, Kyiv, Ukraine
Abstract
Objectives: Overcoming drug resistance by altering the medication's characteristics and the tumor microenvironment might be a therapy improvement strategy. Newly used is Pegylated Liposomal Doxorubicin (PLD) but is significantly more effective under the Magnetothermy (Hyperthermy) modification. The optimal dose and cycle of PLD-based neoadjuvant chemotherapy for Breast Cancer (BC) have yet to be determined. Magnetothermy (Hyperthermy) is a treatment for Advanced Breast Cancer (ABC) that uses time-varying magnetic fields to create eddy currents, resulting in tumor heating (<40EC). Enhance the therapeutic benefits resulted from the synergistic effect of Pegylated Liposomal Doxorubicin in a dosedense regimen and Local mild Magnetothermy (Hyperthermy) electromagnetic field effect against chemoresistant advanced breast cancer. Material and Methods. The study included forty-three patients with chemoresistant ABC: First group: 23 patients, who received a PLD 50 mg/m2and regional inductive mild hyperthermia treatment every four week (standard regimen), second group: 20 patients, who received PLD 50 mg/m2 and regional inductive mild hyperthermia treatment every two week (dose-dense regimen). Results: Patients with chemosensitivity (65.12%) reported significantly greater levels of chemotherapyrelated variables compared to those with chemoresistance (34.88%), p = 0.0014. When PLD was given for the second group, chemosensitivity was higher than when given for the first group (15 patients or 75.00% vs 13 patients or 56.52%, respectively p = 0.038). But, when PLD was given for the first group, chemoresistance was higher, than when given for the second group (10 patients or 43.48% vs 5 patients or 25.00%, respectively p = 0.023). Conclusion: Achieving a quicker clinical response for chemoresistant ABC with a PLD dose-dense regimen while minimizing side effects and adverse responses. The complex employment of magnetothermy and pegylated liposomal drugs resulted in synergy of their anticancer action, which allowed to devitalize the tumor parenchyma of breast carcinoma.
Publication Details
Page(s) 59-63
Published Journal: Journal of Pioneering Medical Sciences, Volume: 14, Issue: 1, Year: 2025

Request the full text from PASTIC

Keywords
dosedense regimen, pegylated liposomal doxorubicin, local mild magnetothermy (Hyperthermy), Chemoresistant breast cancer
References
Anand ,Uttpal ,G e .2024 .n e s & D i s e a s e s , v o l . 1 1 , n o . 4 , J u l y 2 0 2 4. , 101211 : 1367-1401.
Yi ,Wenzhe .2023 .Smart drug delivery systems to overcome drug resistance in cancer immunotherapy. ” Cancer Biology & Medicine, 0009(4) : 3941-267.
Fulton Melody D.,Wided Melody D.,April 2023 . .“Liposomes in cancer therapy: How did we start and where are we now. International Journal of Molecular Sciences, 24(7) : .
Hung Chih,Chiang Chih .2020 .The efficacy of pegylated liposomal doxorubicin-based neoadjuvant chemotherapy in breast cancer: A retrospective case-control study in Taiwan.” Biochemistry Research I n t e r n a t i o n a l , v o l . 2 0 2 0 , A p r i l 2 0 2 0. , : 1-9.
Xu ,Aoshu .2021 .Progressive study on the non-thermal effects of magnetic field therapy in oncology. , 638146 : .
Volodimirovich Movchan,Oleksii Movchan . .Advanced chemoresistant luminal B breast cancer patients' treatment improvement by a combination of liposomal pegylated doxorubicin and local Magnetothermy (regional inductive mild hyperthermia) compared to dose-dense therapy and local Magnetothermy (regional inductive mild hyperthermia).” International Journal of Chemical and Biochemical S c i e n c e s , v o l . 2 4 , n o . 6 , 2 0 2 3. , 5 9 7 - 6 0 : .
NCCN .2024 .Guidelines for Treatment of Cancer by Type. Breast Cancer. Version 4, : .
Syvak L .2017 .Magnetothermy of malignant neoplasms. ” Clinicaloncology, 2(26) : 66-70.
Matikas ,Alexios .2024 ./improved-survival-for-breast-cancer-patients-withdose-dense-chemotherapy. ” Journal of Clinical Oncology, 42(26) : 3077-3082.
Decker .2019 .Victoria: A randomised phase ii study to compare vinorelbine in combination with the mtor inhibitor everolimus versus vinorelbine monotherapy for second-line chemotherapy in advanced her2-negative breast cancer. ” Breast Cancer Research and Treatment, 176(3) : 637-647.
Nel ,Janske .2022 .Functionalized liposomes for targeted breast cancer drug delivery. ” Bioactive Materials, 12 : 401-437.
Kaur ,Ishdeep ,April 2023 . .Combination of chemotherapy and mild hyperthermia using targeted nanoparticles: A potential treatment modality for breast cancer. ” Pharmaceutics, 15(5) : .
0

Citations

0

Downloads

38

Views